The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of local intervention on renal cell carcinoma metastases in patients treated with tyrosine kinase inhibitors (TKIs) stratified by IMDC risk groups.
 
James Ryan Mark
No Relationships to Disclose
 
Caroline Arden Merwarth
No Relationships to Disclose
 
Nicholas Brent Drury
No Relationships to Disclose
 
Yimei Han
No Relationships to Disclose
 
James Thomas Symanowski
Consulting or Advisory Role - Antigen Express; Astellas Pharma; Endocyte (Inst); Lilly; ProNAi; Ra Pharma (Inst)
 
Asim Amin
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Speakers' Bureau - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Argos Therapeutics; Bristol-Myers Squibb; Merck; Prometheus
 
Kris E Gaston
No Relationships to Disclose
 
Stephen Boyd Riggs
Stock and Other Ownership Interests - Acceleron Pharma; Exelixis
Patents, Royalties, Other Intellectual Property - Pulzar
Travel, Accommodations, Expenses - Ethicon
Other Relationship - Intuitive Surgical